- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Medicamen Organics Limited has secured an order valued at ₹ 6.28 Cr for the supply of 739,000 units of Povidone Iodine 10% Solution, a widely used antiseptic. This significant order is expected to enhance the company's revenue in the upcoming quarters and indicates a robust demand for its products in the healthcare sector. The achievement underscores Medicamen's strong reputation for delivering high-quality pharmaceutical solutions and reflects a consistent commitment to meeting market needs.
The company's strategic focus on expanding its international presence, demonstrated through direct exports to various countries in Africa and Southeast Asia, positions it well for future growth. With two WHO GMP-approved manufacturing facilities and a model centered on B2B contract manufacturing, Medicamen is well-equipped to leverage opportunities in the pharmaceutical market. This recent order reinforces investor confidence, presenting a positive outlook as Medicamen continues to solidify its position in the industry.